EGFR and head and neck squamous cell carcinoma: At clinical level, there is no effective therapy for HNSCC; the therapeutic options include surgery in combination with radiotherapy, chemotherapy or targeted approaches such as epidermal growth factor receptor (EGF‐R) inhibitor (Cetuximab).